The Legal Issue
The core legal issue before the Supreme Court was whether a blacklisting order imposed on a drug supplier for alleged quality failure could be sustained when the supplier was denied the statutory right to have the drug sample retested by the Central Drugs Laboratory (CDL) under Section 25(4) of the Drugs and Cosmetics Act, 1940. The State of Himachal Pradesh had blacklisted the supplier based on a single test report, without affording the supplier the opportunity to challenge the report through a retest.
Court's Reasoning
The Supreme Court emphasized the mandatory nature of Section 25(4) of the Drugs and Cosmetics Act, 1940, which grants a manufacturer or supplier the right to notify the Drug Inspector within 28 days of receiving the test report that they intend to adduce evidence to controvert the report. This provision implicitly includes the right to have the sample retested by the CDL, whose report is conclusive evidence. The Court held that denying this opportunity amounted to a violation of the principles of natural justice, as the supplier was deprived of a fair chance to defend itself against the allegations of supplying substandard drugs. The blacklisting order, being a civil consequence with severe repercussions for the supplier's business, could not be imposed without strict adherence to the prescribed statutory procedure and principles of fairness.
Why It Matters
This decision is significant as it reinforces the importance of procedural fairness and strict compliance with statutory provisions, particularly when imposing severe penalties like blacklisting. For drug manufacturers and suppliers, it clarifies that the right to retesting under Section 25(4) of the Drugs and Cosmetics Act, 1940, is a crucial safeguard against arbitrary blacklisting. For government procurement agencies, the ruling serves as a reminder that they must scrupulously follow all statutory procedures, including providing opportunities for retesting, before taking adverse actions against suppliers. Failure to do so will render such actions legally unsustainable, potentially leading to their quashing by higher courts.